Search results
Results from the WOW.Com Content Network
New research published in has found evidence that the use of semaglutide medications, like Ozempic may help reduce the risk of obesity-associated cancers in people with type 2 diabetes.
How and why the drugs have such wide-ranging health benefits is subject to further research, and the GLP-1 drugs were found to increase risks of some conditions, including kidney stones and low ...
Ozempic and similar medications may help reduce bodily inflammation, which is a risk factor for dementia, says Verna Porter, MD, a neurologist and director of the Dementia, Alzheimer’s Disease ...
The review authors noted that research into the potential brain benefits of GLP-1 medications needs more research but are optimistic about the future of these drugs in how they may boost brain health.
Salk Institute researchers have identified a key protein that may help users of GLP-1 drugs such as Ozempic and ... cancer cachexia, obesity and complications from its treatment (e.g., GLP-1 ...
Ozempic, the diabetes drug currently enjoying widespread popularity as a weight loss aid and appetite supressant may also act as a preventive measure against certain kinds of cancer, new research ...
A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a neurologist explains the connection. Ozempic Could Cut Alzheimer's Risk By ...
The success of weight loss drugs like Ozempic heavily relies on the effect that they have in your brain, too, according to doctors. This is how GLP-1s impact your mind.